US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 15.600
  • +0.240+1.56%
Close Mar 17 16:00 ET
  • 15.320
  • -0.280-1.79%
Pre 04:13 ET
2.14BMarket Cap-3.03P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Arrowhead Pharmaceuticals Q1 2025 Earnings Date

Currency:USDFeb 10, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
19.05M
2.50M
-16.55M
Miss Est.
+436.47%
-29.60%
-86.88%
EPS
-0.38
-1.39
-1.01
Miss Est.
+69.26%
-12.10%
-264.64%
Buy

Mar 10, 2025

Arrowhead Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 40.814M--
--2025/Q2-- / 118.541M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 40.814M--
--2025/Q2-- / 118.541M--
Feb 10, 20252025/Q12.500M / 19.050M--
Nov 26, 20242024/Q40.000 / 58.913M--
Aug 8, 20242024/Q30.000 / 37.142M--

Unlock Free Earnings Estimates

Arrowhead Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 10, 2025

Buy

  • Buy

    63.64%
  • Hold

    36.36%
  • Sell

    0.00%

Price Target

No Data